Literature DB >> 23531781

Trans fatty acids and cardiovascular health: research completed?

I A Brouwer1, A J Wanders, M B Katan.   

Abstract

This review asks the question if further research on trans fatty acids and cardiovascular health is needed. We therefore review the evidence from human studies on trans fatty acids and cardiovascular health, and provide a quantitative review of effects of trans fatty acid intake on lipoproteins. The results show that the effect of industrially produced trans fatty acids on heart health seen in observational studies is larger than predicted from changes in lipoprotein concentrations. There is debate on the effect of ruminant trans fatty acids and cardiovascular disease. Of special interest is conjugated linoleic acid (CLA), which is produced industrially for sale as supplements. Observational studies do not show higher risks of cardiovascular disease with higher intakes of ruminant trans fatty acids. However, CLA, industrial and ruminant trans fatty acids all raise plasma low-density lipoprotein and the total to high-density lipoprotein ratio. Gram for gram, all trans fatty acids have largely the same effect on blood lipoproteins. In conclusion, the detrimental effects of industrial trans fatty acids on heart health are beyond dispute. The exact size of effect will remain hard to determine. Further research is warranted on the effects of ruminant trans fatty acids and CLA on cardiovascular disease and its risk factors.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23531781     DOI: 10.1038/ejcn.2013.43

Source DB:  PubMed          Journal:  Eur J Clin Nutr        ISSN: 0954-3007            Impact factor:   4.016


  31 in total

1.  Changes in relative and absolute concentrations of plasma phospholipid fatty acids observed in a randomized trial of Omega-3 fatty acids supplementation in Uganda.

Authors:  Xiaoling Song; Pho Diep; Jeannette M Schenk; Corey Casper; Jackson Orem; Zeina Makhoul; Johanna W Lampe; Marian L Neuhouser
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2016-09-30       Impact factor: 4.006

2.  Double Bond Position Plays an Important Role in Delta-9 Desaturation and Lipogenic Properties of Trans 18:1 Isomers in Mouse Adipocytes.

Authors:  P Vahmani; W J Meadus; C Mapiye; P Duff; D C Rolland; M E R Dugan
Journal:  Lipids       Date:  2015-10-17       Impact factor: 1.880

3.  Anti-mutagenic Properties of Mono- and Dienoic Acid Biohydrogenation Products from Beef Fat.

Authors:  Jeyachchandran Visvalingam; Payam Vahmani; David C Rolland; Michael E R Dugan; Xianqin Yang
Journal:  Lipids       Date:  2017-06-17       Impact factor: 1.880

Review 4.  Dietary trans fatty acids and cardiovascular disease risk: past and present.

Authors:  Alice H Lichtenstein
Journal:  Curr Atheroscler Rep       Date:  2014-08       Impact factor: 5.113

5.  Variations in HDL-carried miR-223 and miR-135a concentrations after consumption of dietary trans fat are associated with changes in blood lipid and inflammatory markers in healthy men - an exploratory study.

Authors:  Véronique Desgagné; Simon-Pierre Guay; Renée Guérin; François Corbin; Patrick Couture; Benoit Lamarche; Luigi Bouchard
Journal:  Epigenetics       Date:  2016-04-21       Impact factor: 4.528

Review 6.  Fatty acids and cardiometabolic health: a review of studies in Chinese populations.

Authors:  Liang Sun; Geng Zong; Huaixing Li; Xu Lin
Journal:  Eur J Clin Nutr       Date:  2020-08-14       Impact factor: 4.016

Review 7.  Is there a linear relationship between the dose of ruminant trans-fatty acids and cardiovascular risk markers in healthy subjects: results from a systematic review and meta-regression of randomised clinical trials.

Authors:  Constance Gayet-Boyer; Fanny Tenenhaus-Aziza; Caroline Prunet; Corinne Marmonier; Corinne Malpuech-Brugère; Benoit Lamarche; Jean-Michel Chardigny
Journal:  Br J Nutr       Date:  2014-10-27       Impact factor: 3.718

8.  Potential of trans fats policies to reduce socioeconomic inequalities in mortality from coronary heart disease in England: cost effectiveness modelling study.

Authors:  Kirk Allen; Jonathan Pearson-Stuttard; William Hooton; Peter Diggle; Simon Capewell; Martin O'Flaherty
Journal:  BMJ       Date:  2015-09-15

Review 9.  Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment.

Authors:  Albert Wiegman; Samuel S Gidding; Gerald F Watts; M John Chapman; Henry N Ginsberg; Marina Cuchel; Leiv Ose; Maurizio Averna; Catherine Boileau; Jan Borén; Eric Bruckert; Alberico L Catapano; Joep C Defesche; Olivier S Descamps; Robert A Hegele; G Kees Hovingh; Steve E Humphries; Petri T Kovanen; Jan Albert Kuivenhoven; Luis Masana; Børge G Nordestgaard; Päivi Pajukanta; Klaus G Parhofer; Frederick J Raal; Kausik K Ray; Raul D Santos; Anton F H Stalenhoef; Elisabeth Steinhagen-Thiessen; Erik S Stroes; Marja-Riitta Taskinen; Anne Tybjærg-Hansen; Olov Wiklund
Journal:  Eur Heart J       Date:  2015-05-25       Impact factor: 29.983

Review 10.  Trans fatty acids - A risk factor for cardiovascular disease.

Authors:  Mohammad Perwaiz Iqbal
Journal:  Pak J Med Sci       Date:  2014-01       Impact factor: 1.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.